Vlado Perkovic

Vlado Perkovic
Born (1969-03-08) March 8, 1969
Residence Sydney, Australia
Alma mater University of Melbourne
Occupation -Executive Director of the George Institute for Global Health[1]
-Professor of Medicine at the University of New South Wales[2]
-Renal Physician
-Staff Specialist in Nephrology at the Royal North Shore Hospital[3]
-George Clinical Board Member[4]
-George Clinical Scientific Leader[5]
Employer -Royal Melbourne Hospital (2002-2005)
-Royal North Shore Hospital (2005-present)
-George Institute for Global Health (2007-present)
-George Clinical (2009–present)
-University of Sydney (2012-2017)[6]
-University of New South Wales (2017-present)

Vlado Perkovic (Born March 8, 1969) is an Australian renal physician and researcher. Perkovic is the Executive Director of The George Institute for Global Health Australia,[1] a global health and medical research institute with headquarters in Sydney, Australia. Perkovic is also a board member and scientific leader at George Clinical,[4] the commercial clinical research arm of The George Institute for Global Health, where he provides trial design and management expertise for a variety of clinical trials, with a focus on the Asia-Pacific.

Career

Perkovic moved to Sydney and into professional academia after completing his PhD in 2005. The thesis undertaken at the University of Melbourne was entitled “The Cardiovascular Aspects of Kidney Disease”.[7] Perkovic relocated to Sydney to take on a position as Associate Principal Director at The George Institute for Global Health (2007-2008), and was appointed Conjoint Senior Lecturer at the University of Sydney.[3] Perkovic worked in a number of senior research and executive positions at The George Institute, before being appointed Executive Director of The George Institute,[1] Australia and Professor of Medicine at the University of Sydney in 2012. In 2017 Perkovic was appointed to lead the non-communicable diseases theme as part of the University of New South Wales Medicine’s thematic research strategy.[2]

From 2009-2014 Perkovic was the Executive Director of George Clinical,[4] one of The George Institute’s commercial enterprises. He was appointed to the board of George Clinical in 2010 and holds this position today. In his current position as Executive Director, he has overall responsibility for the activities and research strategy of The George Institute, Australia. In this role, he is a key member of the organization’s global Senior Management Committee and leads and fosters excellence in research, teaching, professional activities and policy development within and beyond the Institute. Perkovic regularly appears in the media worldwide on behalf of The George Institute[8][9][10] as an authority in the fields hypertension, cardiovascular disease, and clinical trials. His research is widely cited[11] and has been responsible for changing medical guidelines. He has an increasing advocacy and media profile, with a number of op-eds in major newspapers,[12][13][14] as well as chairing a number of roundtables and interviews.[15][16][17][18] For example, Perkovic shared the stage with Dr Jim Kim, President of The World Bank, when he visited Sydney in 2014.[19]

Perkovic is a fellow of the Royal Australasian College of Physicians (1999), the American Society of Nephrology, (2008) and the Australian Academy of Health and Medical Sciences (2016). He holds a National Health and Medical Research Council Senior Research Fellowship and a program grant. Perkovic currently sits on the boards of a number of committees that determine the future strategic direction of health care and research in Australia. Some of Perkovic’s current positions include being a member of the Health Translation Advisory Committee (HTAC) of the National Health and Medical Research Council (2015-), Chairman of the International Society of Nephrology Advancing Clinical Trials initiative (ISN-ACT 2016-), a member of the Executive Committee and Board of Australian Clinical Trials Alliance, (2016-), and a member of the Executive Operations Secretariat, Australasian Kidney Trials Network (2016-, previous Chair of the Scientific Committee 2013-6)

Research Focus and Publications

Perkovic’s has published more than 200 peer reviewed papers,[20] and his career has been based on clinical research investigating the prevention and treatment of kidney disease, and its complications. As well as epidemiological research identifying important risk factors, Perkovic has led a broad suite of clinical trials and meta-analyses aiming to identify effective interventions that slow the progression of kidney disease and reduce the risk of developing the many complications of kidney disease. Some of Perkovic’s key outputs here have been work on diabetic nephropathy published in a range of journals,[20] and studies of blood pressure lowering, lipid lowering and a range of other interventions for the prevention of kidney failure and cardiovascular outcomes in people with kidney disease. Perkovic’s ongoing work includes further systematic reviews, large scale global trials of steroids for the prevention of kidney failure in IgA nephropathy (Co-Principal Investigator), and Steering Committee roles in a number of global, pharma-funded trials studying treatments for the prevention of kidney failure in diabetic nephropathy. This includes a role as Chair of the CREDENCE trial Steering Committee, studying the effects of the SGLT2 inhibitor canagliflozin on the risk of kidney failure and cardiovascular outcomes in people with diabetes and kidney disease.

Perkovic’s research has led to major publications in the New England Journal of Medicine,[21] Lancet,[22] BMJ,[23] Annals of Internal Medicine,[24] PLoS Medicine[25] and a range of specialty journals.

Personal life

Perkovic was born in Brinje, Croatia and moved to Australia with his family before the age of one. He lived in Melbourne and trained in medicine at the University of Melbourne and the Royal Melbourne Hospital, receiving his MBBS and Doctor of Philosophy qualifications from The University of Melbourne in 1992 and 2005 respectively. He is married with three sons. Prior to pursuing a career in academia, he worked as a nephrologist and general physician at the Royal Melbourne Hospital, (2002-2005), and was appointed Head of Haemodialysis for the North West Dialysis Service, Royal Melbourne Hospital. From 2005 when he moved to Sydney, Perkovic has held a part-time appointment as a specialist in nephrology and hypertension at the Royal North Shore Hospital, Sydney.

References

  1. 1 2 3 "Institute Directors". Georgeinstitute.org.au=. 12 April 2013. Retrieved 8 October 2017.
  2. 1 2 z8922934 (26 May 2017). "UNSW and The George Institute mark new era in Australian health research". Newsroom.unsw.edu.au. Retrieved 8 October 2017.
  3. 1 2 "Professor Vlado Perkovic - University of Technology Sydney". Uts.edu.au. Retrieved 8 October 2017.
  4. 1 2 3 "Board of Directors - George Clinical - Leading Asia Pacific CRO". Georgeclinical.com. Retrieved 8 October 2017.
  5. ↑ "Scientific Leaders - George Clinical - Leading Asia Pacific CRO". Georgeclinical.com. Retrieved 8 October 2017.
  6. ↑ Sydney, The University of. "Find a researcher - Sydney Medical School - The University of Sydney". sydney.edu.au. Retrieved 8 October 2017.
  7. ↑ Perkovic, Vlado; Ninomiya, Toshiharu; Arima, Hisatomi; Gallagher, Martin; Jardine, Meg; Cass, Alan; Neal, Bruce; MacMahon, Stephen; Chalmers, John (1 October 2007). "Chronic Kidney Disease, Cardiovascular Events, and the Effects of Perindopril-Based Blood Pressure Lowering: Data from the PROGRESS Study". Journal of the American Society of Nephrology. 18 (10): 2766–2772. doi:10.1681/ASN.2007020256. PMID 17804673. Retrieved 8 October 2017 – via jasn.asnjournals.org.
  8. ↑ "The search the world's first truly affordable dialysis machine". Abc.net.au. 16 March 2015. Retrieved 8 October 2017.
  9. ↑ Healy, Melissa (9 November 2015). "Getting your blood pressure even lower: Here are the risks and rewards". Los Angeles Times. Retrieved 8 October 2017.
  10. ↑ "Teacher turns lifesaver for pupil". Dailytelegraph.com.au. Retrieved 8 October 2017.
  11. ↑ "Vlado Perkovic - Google Scholar Citations". scholar.google.com. Retrieved 8 October 2017.
  12. ↑ "Boost for research careers". Theaustralian.com.au. 21 November 2014. Retrieved 8 October 2017.
  13. ↑
  14. ↑ PERKOVIC, VLADO (15 April 2013). "Disease burden demands fight on several fronts". The Sydney Morning Herald. Retrieved 8 October 2017.
  15. ↑ "Blood pressure risks rise". Au.news.yahoo.com. Retrieved 8 October 2017.
  16. ↑ "Affordable Dialysis Prize Announced, Health Check - BBC World Service". BBC. Retrieved 8 October 2017.
  17. ↑ "Resistant hypertension". Thinkgp.com.au. 2 June 2014. Retrieved 8 October 2017.
  18. ↑ "Professor Vlado Perkovic - University of Technology Sydney". Uts.edu.au. Retrieved 8 October 2017.
  19. ↑ "Transcript of Event:". Worldbank.org. Retrieved 8 October 2017.
  20. 1 2 Search Results for author Perkovic V on PubMed.
  21. ↑ Perkovic, Vlado; Rodgers, Anthony (2015). "Redefining Blood-Pressure Targets — SPRINT Starts the Marathon". New England Journal of Medicine. 373 (22): 2175–8. doi:10.1056/NEJMe1513301. PMID 26551394.
  22. ↑ Liyanage, Thaminda; Ninomiya, Toshiharu; Jha, Vivekanand; Neal, Bruce; Patrice, Halle Marie; Okpechi, Ikechi; Zhao, Ming-hui; LV, Jicheng; Garg, Amit X; Knight, John; Rodgers, Anthony; Gallagher, Martin; Kotwal, Sradha; Cass, Alan; Perkovic, Vlado (2015). "Worldwide access to treatment for end-stage kidney disease: A systematic review". The Lancet. 385 (9981): 1975–82. doi:10.1016/S0140-6736(14)61601-9. PMID 25777665.
  23. ↑ Perkovic, V; Cass, A (2010). "Glomerular filtration rate and the risk of stroke". BMJ. 341: c4390. doi:10.1136/bmj.c4390. PMID 20884697.
  24. ↑ Palmer, Suetonia C; Di Micco, Lucia; Razavian, Mona; Craig, Jonathan C; Perkovic, Vlado; Pellegrini, Fabio; Copetti, Massimiliano; Graziano, Giusi; Tognoni, Gianni; Jardine, Meg; Webster, Angela; Nicolucci, Antonio; Zoungas, Sophia; Strippoli, Giovanni F.M (2012). "Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons with Chronic Kidney Disease". Annals of Internal Medicine. 156 (6): 445–59. doi:10.7326/0003-4819-156-6-201203200-00007. PMID 22431677.
  25. ↑ Perkovic, Vlado; Verdon, Christine; Ninomiya, Toshiharu; Barzi, Federica; Cass, Alan; Patel, Anushka; Jardine, Meg; Gallagher, Martin; Turnbull, Fiona; Chalmers, John; Craig, Jonathan; Huxley, Rachel (2008). "The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis". PLoS Medicine. 5 (10): e207. doi:10.1371/journal.pmed.0050207. PMC 2570419. PMID 18942886.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.